Joint Filing Agreement

Exhibit 1

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, par value US$0.001 per share, of ShangPharma Corporation, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[Remainder of this page has been left intentionally blank.]

SIGNATURE

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of July 16, 2012.

Xxxxxxx Xxx Xxx				/s/ Xxxxxxx Xin Xxx
				Xxxxxxx Xxx Xxx
The 2012 Xxxxxxx Xxx Xxx Irrevocable Qualified Annuity Trust				/s/ Xxxxxxx Xxxxxx
				Name: Xxxxxxx Xxxxxx
				Title: Vice President – Trust Officer
				On behalf of Citicorp Trust, N.A., as trustee of The 2012 Xxxxxxx Xxx Xxx Irrevocable Qualified Annuity Trust
The Hui Trust				/s/ Xxxxxxx Xxxxxx
				Name: Xxxxxxx Xxxxxx
				Title: Vice President – Trust Officer
				On behalf of Citicorp Trust, N.A., as trustee of The Hui Trust
Hui Family Trust				/s/ Xxxxxx Xxxxxxx
				Name: Xxxxxx Xxxxxxx
				Title: Authorized Signatory
				On behalf of Managecorp Limited of Portcullis TrustNet Xxxxxxxx, as trustee of Hui Family Trust
ChemPartner Investment Holdings Limited				/s/ Xxxxxxx Xxx Xxx
				Name: Xxxxxxx Xxx Xxx
				Title: Director
ChemExplorer Investment Holdings Ltd.				/s/ Xxxxxxx Xxx Xxx
				Name: Xxxxxxx Xxx Xxx
				Title: Director